Anti-CLEC4F Antibody [10-A6-1]

HUABIO

Anti-CLEC4F Antibody [10-A6-1]

7

Flow Cytometry, Western Blot

WB,FC

Research Use Only

Monoclonal

10-A6-1

2 mg/ml

Unconjugated

CLEC4F

C-type lectin domain family 4 member F

CLECSF13, KCLR, KCR, C-type lectin domain family 4 member F, C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamily member 13

Mouse

IgG1

C-type lectin domain family 4 member F

CLEC4F, a member of C-type lectin, was first purified from rat liver extract with high binding affinity to fucose, galactose (Gal), N-acetylgalactosamine (GalNAc), and un-sialylated glucosphingolipids with GalNAc or Gal terminus. CLEC4F is a heavily glycosylated membrane protein co-expressed with F4/80 on Kupffer cells. In contrast to F4/80, CLEC4F is detectable in fetal livers at embryonic day 11.5 (E11.5) but not in yolk sac, suggesting the expression of CLEC4F is induced as cells migrate from yolk cells to the liver. Even though CLEC4F is not detectable in tissues outside liver, both residential Kupffer cells and infiltrating mononuclear cells surrounding liver abscesses are CLEC4F-positive upon Listeria monocytogenes (L. monocytogenes) infection. While CLEC4F has strong binding to Gal and GalNAc, terminal fucosylation inhibits CLEC4F recognition to several glycans such as Fucosyl GM1, Globo H, Bb3~4 and other fucosyl-glycans. Moreover, CLEC4F interacts with alpha-galactosylceramide (alpha-GalCer) in a calcium-dependent manner and participates in the presentation of alpha-GalCer to natural killer T (NKT) cells. This suggests that CLEC4F is a C-type lectin with diverse binding specificity expressed on residential Kupffer cells and infiltrating monocytes in the liver, and may play an important role to modulate glycolipids presentation on Kupffer cells.

Human

Human

-20°C,2°C to 8°C

41116161